Merck Company Stock Performance
| MRK Stock | USD 125.37 0.31 0.25% |
Merck has a performance score of 7 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.82, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Merck's returns are expected to increase less than the market. However, during the bear market, the loss of holding Merck is expected to be smaller as well. Merck Company right now secures a risk of 1.09%. Please verify Merck Company skewness, and the relationship between the value at risk and day median price , to decide if Merck Company will be following its current price movements.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Merck Company are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite sluggish basic indicators, Merck may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Actual Historical Performance (%)
One Day Return 0.25 | Five Day Return (1.31) | Year To Date Return 10.71 | Ten Year Return 129.66 | All Time Return 31.6 K |
Forward Dividend Yield 0.0246 | Payout Ratio 0.02 | Last Split Factor 1048:1000 | Forward Dividend Rate 3.08 | Dividend Date 2024-04-05 |
1 | Acquisition by Mary Coe of 227 shares of Merck subject to Rule 16b-3 | 03/28/2024 |
2 | LOBOS 1707 TEQUILA PARTNERS WITH TO LAUNCH A LIMITED-EDITION REPOSADO BOTTLE TO SUPPORT LIFE-SAVING PROGRAMS THAT FIGHT AIDS | 04/02/2024 |
| Merck dividend paid on 5th of April 2024 | 04/05/2024 |
4 | Obituary James Swifty W. Swift, 83, Of Milford | 04/09/2024 |
5 | Look Up and See the Future | 04/10/2024 |
6 | Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans | 04/11/2024 |
7 | Award-Winning and Banned Book Author Launches Next Queer Leadership Book | 04/12/2024 |
8 | Better Growth Play Merck or The Vanguard Growth Index Fund | 04/15/2024 |
9 | Disposition of 6224 shares by Smart Dalton of Merck at 117.89 subject to Rule 16b-3 | 04/17/2024 |
| Begin Period Cash Flow | 12.8 B |
Merck |
Merck Relative Risk vs. Return Landscape
If you would invest 11,814 in Merck Company on January 19, 2024 and sell it today you would earn a total of 723.00 from holding Merck Company or generate 6.12% return on investment over 90 days. Merck Company is generating 0.1001% of daily returns assuming volatility of 1.0884% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than Merck, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Merck Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merck's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Merck Company, and traders can use it to determine the average amount a Merck's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0919
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | MRK | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.09 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Merck is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merck by adding it to a well-diversified portfolio.
Merck Fundamentals Growth
Merck Stock prices reflect investors' perceptions of the future prospects and financial health of Merck, and Merck fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Merck Stock performance.
| Return On Equity | 0.009 | ||||
| Return On Asset | 0.0264 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.0008 % | ||||
| Current Valuation | 345.96 B | ||||
| Shares Outstanding | 2.53 B | ||||
| Price To Earning | 18.05 X | ||||
| Price To Book | 8.48 X | ||||
| Price To Sales | 5.30 X | ||||
| Revenue | 59.87 B | ||||
| Gross Profit | 42.08 B | ||||
| EBITDA | 6.85 B | ||||
| Net Income | 365 M | ||||
| Cash And Equivalents | 12.69 B | ||||
| Cash Per Share | 4.44 X | ||||
| Total Debt | 36.27 B | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 14.85 X | ||||
| Cash Flow From Operations | 13.01 B | ||||
| Earnings Per Share | 0.14 X | ||||
| Market Capitalization | 316.78 B | ||||
| Total Asset | 106.67 B | ||||
| Retained Earnings | 53.9 B | ||||
| Working Capital | 6.47 B | ||||
| Current Asset | 29.76 B | ||||
| Current Liabilities | 19.2 B | ||||
About Merck Performance
To evaluate Merck Company Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Merck generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Merck Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Merck Company market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Merck's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 145.25 | 159.39 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | 0 | 0 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Merck Company performance evaluation
Checking the ongoing alerts about Merck for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Merck Company help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 79.0% of the company shares are owned by institutional investors | |
| On 5th of April 2024 Merck paid $ 0.77 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Disposition of 6224 shares by Smart Dalton of Merck at 117.89 subject to Rule 16b-3 |
- Analyzing Merck's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Merck's stock is overvalued or undervalued compared to its peers.
- Examining Merck's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Merck's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Merck's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Merck's stock. These opinions can provide insight into Merck's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.453 | Dividend Share 2.92 | Earnings Share 0.14 | Revenue Per Share 23.695 | Quarterly Revenue Growth 0.058 |
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.